Mobrine 5mg Tablet IR
By Mobrine
Rx
10 Tablet IR in a Strip

Composition
Cyclobenzaprine(5mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
August, 2025

liver
Caution should be taken when using Mobrine 5mg Tablet IR in patients with liver disease. It may be necessary to adjust the dosage of the medication, and it is important to consult your doctor before starting treatment. It is not advisable to use Mobrine 5mg Tablet IR in patients with moderate to severe liver disease. If you have any liver issues, please speak to your doctor before taking this medication.

kidney
There is limited information on using Mobrine 5mg Tablet IR in patients with kidney disease. Consult your doctor for guidance.

alcohol
When taking Mobrine 5mg Tablet IR, be cautious as it can lead to increased drowsiness when consumed with alcohol.

driving
Mobrine 5mg Tablet IR can cause side effects that may impact your driving abilities. If you experience symptoms that impair focus or reaction time, avoid driving.

pregnancy
Mobrine 5mg Tablet IR is likely safe during pregnancy based on animal studies showing minimal effects on the developing baby. Human studies are limited.

breastfeeding
Mobrine 5mg Tablet IR should be avoided during breastfeeding as it may pass into breastmilk and harm the baby. Discuss with your doctor before using this medication.
Habit Forming | No |
Chemical Class | Dibenzocycloheptenes Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Skeletal muscle relaxant- Centrally acting |
₹55
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025